Oral anticoagulants and concurrent rifampin administration in tuberculosis patients with non-valvular atrial fibrillation

Oral anticoagulants and concurrent rifampin administration in tuberculosis patients with non-valvular atrial fibrillation

Abstract Background Evidence and guidelines for Non-vitamin K antagonist oral anticoagulants (NOACs) use when prescribing concurrent rifampin for tuberculosis treatment in patients with non-valvular atrial fibrillation (NVAF) are limited. Methods Using the Korean National Health Insurance Service da...

Full description

Bibliographic Details
Main Authors: Ki Won Hwang, Jin Hee Choi, Soo Yong Lee, Sang Hyun Lee, Min Ku Chon, Jungkuk Lee, Hasung Kim, Yong-Giun Kim, Hyung Oh Choi, Jeong Su Kim, Yong-Hyun Park, June Hong Kim, Kook Jin Chun, Gi-Byoung Nam, Kee-Joon Choi
Format: Article
Language:English
Published: BMC 2023-04-01
Series:BMC Cardiovascular Disorders
Subjects:
Atrial fibrillation
Tuberculosis
Anticoagulation
Rifampin
Drug-drug interactions
Online Access:https://doi.org/10.1186/s12872-023-03212-z

Internet

https://doi.org/10.1186/s12872-023-03212-z

Similar Items